Osiris Therapeutics Inc. (OSIR) Sees Large Volume Increase
Osiris Therapeutics Inc. (NASDAQ:OSIR) shares saw unusually-strong trading volume on Friday . Approximately 53,499 shares traded hands during mid-day trading, an increase of 5% from the previous session’s volume of 50,990 shares.The stock last traded at $5.18 and had previously closed at $5.24.
The stock has a market cap of $178.46 million and a PE ratio of 123.33. The company’s 50-day moving average price is $5.16 and its 200 day moving average price is $5.60.
An institutional investor recently raised its position in Osiris Therapeutics stock. GSA Capital Partners LLP boosted its position in shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned 0.29% of Osiris Therapeutics worth $1,027,000 as of its most recent SEC filing.
Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.